Spring Bank Pharmaceuticals Nasdaq Listed Banner

Investor FAQs

Show all

Spring Bank was incorporated under the laws of the Commonwealth of Massachusetts as Spring Bank Technologies, Inc. on October 7, 2002. On May 12, 2008, the Company filed a certificate of incorporation in the State of Delaware and changed its state of incorporation to Delaware and changed its name to Spring Bank Pharmaceuticals, Inc.
The principal executive offices are located at 86 South Street, Hopkinton, MA 01748 (508) 473-5993
December 31st
Spring Bank is traded on the NASDAQ stock exchange under the symbol “SBPH.”
Spring Bank completed its initial public offering on May 11, 2016 at $12 per share.
Shares can be purchased through a stockbroker of your choice.
Spring Bank does not offer a direct stock purchase plan.
Currently, Spring Bank does not offer a dividend or dividend reinvestment plan.
Correspondence should be mailed to:
P.O. Box 505000
Louisville, KY  40233
Overnight correspondence should be sent to:
462 South 4th Street, Suite 1600
Louisville, KY 40202
Please contact the transfer agent.
Quarterly & Annual reports and other investor materials are available under “Financial Information” in the “Investors & Media” section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov
Jonathan Freve
Chief Financial Officer, Treasurer and Secretary
Investors can sign up for email alerts on the Investors & Media section of the Spring Bank website.
Investors can submit questions through the Investors & Media section of the Spring Bank website.